IAG provide a full package
solution for DXA studies
From Data to Discovery: The Art of DXA Analysis in Research
You missed the live of our experts?
Lucky you, you can rewatch the webinar here!
MAKE OUR EXPERT TEAM YOUR NEW PARTNERS
– Time concerned: in R&D and Clinical Development, every day is important, not only for the people developing on a new compound, but mostly for patients waiting for a new hope. At IAG, we work every second to make the difference.
– Result oriented: Imaging analysis can be challenging in a trial, from the end points selection to the protocol realization on multiple sites. Our previous experience shaped our processes to guarantee smooth collaboration and accurate data production.
– Reliable expertise: Started 16 years ago in a small office in Leeds, UK, IAG built a strong experience in Imaging studies and hired best talents to support sponsors projects and face Life Science challenges.
– A 360° service: with offices located all around the world, our constantly growing team guarantees responsive and accountable support to manage all queries before they become your issues.
– Price minded: Not only confident in our day-to-day work, but we also attach importance to deliver the highest scientific value at the best cost for our partners. Signing with IAG is a guarantee of a successful, right priced, and long-term collaboration.
IAG’S QUALITY & EFFICIENCY
We understand time is precious for everyone, even more during clinical development steps. Our platform is built to process in strong and fast imaging analysis and deliver with an incomparable speed precise reports to help quick and conscious decisions.
With more than 400 studies supported in total, and +40 specifically including DXA, our team became a trusted partner in the clinical imaging field.
In 2021, IAG had been contacted by a European company to support their Phase III trial. The objective was to use X-ray and DXA scans for combined eligibility as one of the criteria for the inclusion/exclusion of patients into the protocol.
Our sponsor has chosen us for our expertise on the field, our global network, and our proprietary platform where analysis was made in real time, and the result shared with the different parties.
+1200 patients
+50 Sites in all Europe
0.4 day from the upload to the QC report
2.2 days from QC report to Final Report
DYNAMIKA
hosted all the DXA and X-ray images and analysis
KEY TO DXA STUDY SUCCESS
Reproducibility: Properly acquired and correctly analysed DXA scans result in very low precision error which allows detection of subtle changes over time.
Validity: Evaluating and monitoring instrument calibration over the course of your study is vital to validating patient BMD results. IAG ensures that Instrument Quality Control (IQC) data are being collected correctly and available for analysis and to support patient results.
Accessibility: IAG has worked with many imaging facilities and can recommend high-performing DXA Sites for your study, reducing risk and improving patient recruitment.
Transparency: DYNAMIKA is a proprietary, secure image transfer and processing system that provides real-time access to tracking information throughout the study.
Would you be interested in receiving regular updates and
staying informed with the latest news?
We invite you to subscribe to our newsletter.
MULTIPLE SITES & ONE STUDY: SIMPLIFY THE DATA MANAGEMENT
Driven by our collective experiences of the challenges within multi-sites clinical trials, our teams developed DYNAMIKA, ensuring a secured data management and accelerating workflows through a centralized imaging analysis solution. With over 400 clinical studies and more than 4,000 sites powered around the world, our state of arts platform demonstrated its efficiency to process faster imaging data from thousands of patients.
Cost-Effective, Compliant and Cloud based, DYNAMIKA helps you to follow in real time the study protocols and activities of all the partners and accelerates results analysis and delivery, empowering swift and informed decisions. With a commitment to security and compliance, our products and processes adhere rigorously to ISO13485 and 21 CFR Part 11 requirements.
MORE THAN A PARTNER, AN EXTENSION OF YOUR TEAM
Partnering with us will be your insurance for a powerful and mutual comprehensive collaboration as many before you, with DXA or other imaging technology. On each project, you’ll have a team of experts working with you and on whom you can rely.
Discover more about the partners who trusted us before you.
![The image above is allustrating DCE MRI maps of a treatment responder pre-SABR (a-d) and post-SABR (e-h) including (left-right) IRE, AUC, Ktrans and Ve with tumour outlined in orange, generated with Dynamika [4]. The corresponding slice between pre-SABR and post-SABR scans.](https://www-test.ia-grp.com/wp-content/uploads/2017/09/RCC-400x377.jpg "RCC")
